Proceed, with caution: SPECT cerebral blood flow studies of children and adolescents with attention deficit hyperactivity disorder

Journal of Nuclear Medicine

Volumn 43, Issue 12, 2002, Pages 1630-1633

  Castellanos, F Xavier ^a  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHYLPHENIDATE; XENON 133;

ATTENTION DEFICIT DISORDER; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; BRAIN TOMOGRAPHY; CLINICAL TRIAL; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DOPAMINE RELEASE; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; NEUROLOGIC DISEASE; NOMENCLATURE; NOTE; PRIORITY JOURNAL; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CEREBROVASCULAR CIRCULATION; CHILD; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPHENIDATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036900004     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (29)

1. Langleben DD, Acton PD, Elman I, et al. Effects of methylphenidate treatment discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. J Nucl Med. 2002;43:1624-1629.
2. Bell RD, Alexander GM, Schwartzman RJ. Methylphenidate decreases local glucose metabolism in the motor cortex. Pharmacol Biochem Behav. 1983;18:1-5.
3. Devous MD Sr, Trivedi MH, Rush AJ. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. J Nucl Med. 2001;42:535-542.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC: American Psychiatric Association; 1994.
5. Langleben DD, Austin G, Krikorian G, Ridlehuber HW. Goris ML, Strauss HW. Interhemispheric asymmetry of regional cerebral blood flow in pre-pubescent boys with attention deficit hyperactivity disorder. Nucl Med Commun. 2001;22:1333-1340.
6. Lou HC, Henriksen L, Bruhn P. Focal cerebral dysfunction in developmental learning disabilities. Lancet. 1990;335:8-11.
7. Lou HC, Henriksen L, Bruhn P. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol. 1984;41:825-829.
8. Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol. 1989;46:48-52.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Ed. Washington, DC: American Psychiatric Association; 1987.
10. Lou HC. Cerebral glucose metabolism in hyperactivity [letter]. N Engl J Med. 1991;324:1216-1217.
11. 99mTc-ECD. Eur J Nucl Med. 1997;24:1245-1252.
12. Amen DG, Paldi JH, Thisted RA. Brain SPECT imaging [letter]. J Am Acad Child Adolesc Psychiatry. 1993;32:1080-1081.
13. Gustafsson P, Thernlund G, Ryding E, Rosen I, Cederblad M. Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD). Acta Paediatr. 2000;89:830-835.
14. Spalletta G, Pasini A, Pau F, Guido G, Menghini L, Caltagirone C. Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities. J Neural Transm. 2001;108:1203-1216.
15. Rossi JS. Statistical power of psychological research: What have we gained in 20 years? J Consult Clin Psychol. 1990;58:646-656.
16. Kim BN, Lee JS, Cho SC, Lee DS. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J. 2001;42:19-29.
17. Arndt S, Cohen G, Alliger RJ, Swayze VW II, Andreasen NC. Problems with ratio and proportion measures of imaged cerebral structures. Psychiatry Res. 1991;40:79-89.
18. Barbour RL, Graber HL, Pei Y, Zhong S, Schmitz CH. Optical tomographic imaging of dynamic features of dense-scattering media. J Opt Soc Am A Opt Image Sci Vis. 2001;18:3018-3036.
19. Franceschini MA, Toronov V, Filiaci ME, Gratton E, Fantini S. On-line optical imaging of the human brain with 160-ms temporal resolution. Optics Express. 2000;6:49-57.
20. Volkow ND, Ding YS, Fowler JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry. 1995;52:456-463.
21. 2 receptors. Am J Psychiatry. 1997;154:50-55.
22. Volkow ND, Wang GJ, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001;21:U1-U5.
23. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density is elevated in patients with attention deficit hyperactivity disorder. Lancet. 1999;354:2132-2133.
24. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett. 2000;285:107-110.
25. van Dyck CH, Quinlan DM, Cretella LM, et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry. 2002;159:309-312.
26. 2 receptor availability associated with response to stimulant medication in ADHD. Dev Med Child Neurol. 2001;43:755-760.
27. Koepp MJ, Gunn RN, Lawrence AD, et al. Evidence for striatal dopamine release during a video game. Nature. 1998;393:266-268.
28. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21:RC157.
29. Volkow ND, Wang GJ, Fowler JS, et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse. 2002:43:181-187.